Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases

The field of epigenetics requires that traditional divisions between scientific disciplines give way to cross-fertilization of concepts and ideas from different areas of investigation. Such is the case with research in autoimmunity. Recent discoveries of stimuli that induce autoimmunity reveal that...

Full description

Bibliographic Details
Main Authors: Marko Radic, Sylviane Muller
Format: Article
Language:English
Published: SAGE Publishing 2013-01-01
Series:Genetics and Epigenetics
Online Access:https://doi.org/10.4137/GEG.S12144
id doaj-4a0c115f8a554469a651b4f81e0b5bf0
record_format Article
spelling doaj-4a0c115f8a554469a651b4f81e0b5bf02020-11-25T01:03:10ZengSAGE PublishingGenetics and Epigenetics1179-237X2013-01-01510.4137/GEG.S12144Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune DiseasesMarko Radic0Sylviane Muller1Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA.Immunopathology and therapeutic chemistry/Laboratory of excellence MEDALIS, Institut de Biologie Molέculaire et Cellulaire, CNRS, Strasbourg, France.The field of epigenetics requires that traditional divisions between scientific disciplines give way to cross-fertilization of concepts and ideas from different areas of investigation. Such is the case with research in autoimmunity. Recent discoveries of stimuli that induce autoimmunity reveal that epigenetic marks of autoantigens are recognized by autoreactive B and T cell receptors. Thus, insights into the initiation of autoimmunity, its prevention and therapy will arise from understanding the biochemistry, cell biology and microbiology of autoantigen epigenetics. Here, we highlight potential benefits from the inhibition of a histone modifying enzyme and the administration of a phosphorylated, spliceosome-derived peptide, in the treatment of autoimmunity.https://doi.org/10.4137/GEG.S12144
collection DOAJ
language English
format Article
sources DOAJ
author Marko Radic
Sylviane Muller
spellingShingle Marko Radic
Sylviane Muller
Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
Genetics and Epigenetics
author_facet Marko Radic
Sylviane Muller
author_sort Marko Radic
title Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
title_short Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
title_full Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
title_fullStr Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
title_full_unstemmed Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
title_sort epigenetics of autoantigens: new opportunities for therapy of autoimmune diseases
publisher SAGE Publishing
series Genetics and Epigenetics
issn 1179-237X
publishDate 2013-01-01
description The field of epigenetics requires that traditional divisions between scientific disciplines give way to cross-fertilization of concepts and ideas from different areas of investigation. Such is the case with research in autoimmunity. Recent discoveries of stimuli that induce autoimmunity reveal that epigenetic marks of autoantigens are recognized by autoreactive B and T cell receptors. Thus, insights into the initiation of autoimmunity, its prevention and therapy will arise from understanding the biochemistry, cell biology and microbiology of autoantigen epigenetics. Here, we highlight potential benefits from the inhibition of a histone modifying enzyme and the administration of a phosphorylated, spliceosome-derived peptide, in the treatment of autoimmunity.
url https://doi.org/10.4137/GEG.S12144
work_keys_str_mv AT markoradic epigeneticsofautoantigensnewopportunitiesfortherapyofautoimmunediseases
AT sylvianemuller epigeneticsofautoantigensnewopportunitiesfortherapyofautoimmunediseases
_version_ 1725202086149226496